Global Connected Drug Delivery Report 2016-2020: Focus on Devices, Markets, Players, Strategies and Forecasts

Dublin, Oct. 26, 2016 -- Research and Markets has announced the addition of the "Connected Drug Delivery - Devices, Markets, Players, Strategies and Forecasts" report to their offering.

For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life.

Connected devices - drug delivery devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants. Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.

What You Will Learn

• What drug delivery devices incorporate connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?
• What benefits do connected drug delivery devices provide to patients in the area of improved adherence? Patient safety and reported outcomes? HCP/patient communication?
• What therapeutic areas are the current focus of connected devices?
• Who are the companies behind the push to connected delivery devices? What are their development activities and corporate alliances and affiliations?
• What is the importance of pharma-device alliances and design partnerships on connected drug delivery device commercialization and market access?
• What does the current market for connected drug delivery devices look like? What will it look like in 2020?
• What are the key market drivers for the growth of connected drug delivery devices?

Key Topics Covered:

1. Executive Summary

2. Connected Devices - The Opportunity

• Drug Development Trends
• The Rapid Rise of Prefilled Devices
• Factors Driving Drug Self-Administration
• Therapeutic Demand Drivers
• The Impact of Developing Economies

3. Wireless Connectivity Technologies

• Bluetooth
• Cellular
• Near Field Communications
• Emerging Technologies

4. Wirelessly Connected Device Analysis

• Inhalation
• Integrated Connected Devices
• Third Party/Aftermarket Connectivity Devices
• Injection
• Connected Handheld Injection Devices
• Connected Wearable Injection Devices
• Vendor-specific Connectivity Platforms
• Third Party Connectivity Devices
• Solid Dosage Forms
• Transdermal Systems

5. Near-term Markets and Applications

• Addiction
• Anaphylaxis
• Autoimmune Diseases
• Cardiovascular
• Diabetes
• Hormone Replacement
• Neurology
• Upper Respiratory Diseases

6. Market Factors

• Regulatory Requirements
• Data Security
• Patient Acceptance and Training

7. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/92gk5t/connected_drug

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Drug Delivery